CONMED CORP (CNMD) Stock Analyst Ratings
USA - NYSE:CNMD - US2074101013 - Common Stock
46.72 USD
-0.6 (-1.27%)
ChartMill assigns a Buy % Consensus number of 73% to CNMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.99. This target is 34.81% above the current price.
CNMD was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CNMD.
In the previous month the buy percentage consensus was at a similar level.
CNMD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-06-12 | Needham | Downgrade | Buy -> Hold |
| 2025-05-01 | Needham | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-06 | Needham | Maintains | Buy -> Buy |
| 2025-02-06 | Stifel | Maintains | Buy -> Buy |
| 2025-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-01 | Needham | Maintains | Buy -> Buy |
| 2024-08-01 | Stifel | Maintains | Buy -> Buy |
| 2024-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Needham | Maintains | Buy -> Buy |
| 2024-05-06 | Needham | Reiterate | Buy -> Buy |
| 2024-04-25 | Needham | Maintains | Buy -> Buy |
| 2024-04-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-01 | Needham | Maintains | Buy -> Buy |
| 2024-02-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-26 | Needham | Maintains | Buy -> Buy |
| 2023-10-26 | Stifel | Maintains | Buy -> Buy |
| 2023-10-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
CONMED CORP / CNMD FAQ
What is the price target for CNMD stock?
12 analysts have analysed CNMD and the average price target is 62.99 USD. This implies a price increase of 34.81% is expected in the next year compared to the current price of 46.72.
What is the consensus rating for CONMED CORP (CNMD) stock?
The consensus rating for CONMED CORP (CNMD) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.